Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The use of MAGE C1 and flow cytometry to determine the malignant cell type in multiple myeloma.

PloS one - 1 Jan 2015

Wienand Kirsty, Shires Karen

Abstract excerpt

The malignant cell phenotype of Multiple Myeloma (MM) remains unclear with studies proposing it to be either clonotypic B or proliferating plasma cells. Cancer/testis antigen MAGE C1 is being extensively studied in MM and it has been suggested that it is involved in the pathogenesis of the cancer. Therefore, we report on the use of MAGE C1 to determine the malignant cell phenotype in MM using flow cytometry. Bone...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Bone Marrow
Share to Cell Lineage

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Clone Cells

Share to Flow Cytometry

Share to Multiple Myeloma

Share to Neoplasm Proteins

Share to V(D)J Recombination

Source

Open in PubMed Open full text

Identifiers

PMID: 25793710
DOI: 10.1371/journal.pone.0120734
PMCID: PMC4368436

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The use of MAGE C1 and flow cytometry to determine the malignant cell type in multiple myeloma.PMID 25793710Read ↗

Circulating plasma cells (either polyclonal or monoclonal) as markers of aggressive Multiple Myeloma phenotypeSemantic proximity Read ↗

Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.Semantic proximity Read ↗

MAGE‐C1/CT‐7 expression in plasma cell myeloma: Sub‐cellular localization impacts on clinical outcomeSemantic proximity Read ↗

[Research progress on multiple myeloma immunophenotyping and minimal residual disease detected by flow cytometry].Semantic proximity Read ↗

Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myelomaSemantic proximity Read ↗

High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma.Semantic proximity Read ↗

Multiparameter Flow Cytometry Identification of Neoplastic Subclones: A New Biomarker in Monoclonal Gammopathy of Undetermined Significance and Multiple MyelomaSemantic proximity Read ↗

Differentiation stage of myeloma plasma cells: biological and clinical significance.Semantic proximity Read ↗

The myeloma stem cell concept, revisited: from phenomenology to operational terms.Semantic proximity Read ↗

Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell developmentSemantic proximity Read ↗

Multiple myeloma: new evidence and insights from the immunoglobulin heavy chain gene and phenotypes.Semantic proximity Read ↗

Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.